PANews reported on February 17 that Andrew MacKenzie, CEO of Agant, a stablecoin issuer specializing in British pounds, stated that the UK's crypto regulatory frameworkPANews reported on February 17 that Andrew MacKenzie, CEO of Agant, a stablecoin issuer specializing in British pounds, stated that the UK's crypto regulatory framework
Agant, a stablecoin issuer specializing in British pounds, predicts that UK crypto legislation may take effect in 2027.
PANews reported on February 17 that Andrew MacKenzie, CEO of Agant, a stablecoin issuer specializing in British pounds, stated that the UK's crypto regulatory framework is on the right track, but its pace of development is insufficient to support the country's ambition to become a global digital asset hub.
MacKenzie believes the UK government has repeatedly pledged to position London as a global hub for crypto and digital asset activities. However, legislation comprehensively covering stablecoins and broader crypto activities is not expected to be approved by Parliament until later this year, and may not come into effect until 2027.
Agant plans to issue a stablecoin called GBPA, fully backed by the British pound. The company has already registered with the UK Financial Conduct Authority (FCA), indicating its intention to target institutional investors, rather than the retail cryptocurrency market. Agant has positioned GBPA as infrastructure for institutional payments, settlements, and tokenized assets.
Market Opportunity
Effect AI Price(EFFECT)
$0,003937
$0,003937$0,003937
USD
Effect AI (EFFECT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Knocking Bitcoin's lack of yield shows your ‘Western financial privilege’
Macro analyst Luke Gromen’s comments come amid an ongoing debate over whether Bitcoin or Ether is the more attractive long-term option for traditional investors. Macro analyst Luke Gromen says the fact that Bitcoin doesn’t natively earn yield isn’t a weakness; it’s what makes it a safer store of value.“If you’re earning a yield, you are taking a risk,” Gromen told Natalie Brunell on the Coin Stories podcast on Wednesday, responding to a question about critics who dismiss Bitcoin (BTC) because they prefer yield-earning assets.“Anyone who says that is showing their Western financial privilege,” he added.Read more
Share
Coinstats2025/09/18 14:22
Ronin Price Prediction 2026-2030: A Strategic Deep Dive into RON’s Critical Juncture
BitcoinWorld Ronin Price Prediction 2026-2030: A Strategic Deep Dive into RON’s Critical Juncture As the blockchain gaming sector enters a pivotal phase of maturation
Share
bitcoinworld2026/02/17 19:30
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves
The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11